Revenio Group Oyj 2024 SR
The report highlights Revenio's transition to a comprehensive eye care solution provider, achieving net sales of EUR 103.5 million in 2024. Key milestones include the acquisition of Thirona Retina to enhance AI capabilities and the completion of a double materiality assessment in preparation for CSRD. The company improved its emission calculation capacity, reporting Scope 1 and 2 emissions of 243 tCO2e, and initiated Scope 3 mapping. Social highlights include a 4th place ranking in the Nordic Business Diversity Index and a high employee engagement score of 3.84/5.
Company: Revenio Group Oyj
Sector: Health Care
Country: Finland
Year: 2024
Type: SR
Pages: 46
Revenio Group Oyj
Sustainability Report
The report highlights Revenio's transition to a comprehensive eye care solution provider, achieving net sales of EUR 103.5 million in 2024. Key milestones include the acquisition of Thirona Retina to enhance AI capabilities and the completion of a double materiality assessment in preparation for CSRD. The company improved its emission calculation capacity, reporting Scope 1 and 2 emissions of 243 tCO2e, and initiated Scope 3 mapping. Social highlights include a 4th place ranking in the Nordic Business Diversity Index and a high employee engagement score of 3.84/5.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Published
Mar 19, 2025
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Women on Board
Women in Management
Employees